Molecular Epidemiology of Mycobacterium tuberculosis in Western Sweden

  title={Molecular Epidemiology of Mycobacterium tuberculosis in Western Sweden},
  author={K. Brudey and M. Gordon and P. Mostr{\"o}m and L. Svensson and Bodil Jonsson and C. Sola and M. Ridell and Nalin Rastogi},
  journal={Journal of Clinical Microbiology},
  pages={3046 - 3051}
  • K. Brudey, M. Gordon, +5 authors Nalin Rastogi
  • Published 2004
  • Medicine, Biology
  • Journal of Clinical Microbiology
  • ABSTRACT The genetic diversity of Mycobacterium tuberculosis isolates among patients from Sweden was determined by a combination of two PCR-based techniques (spoligotyping and variable number of tandem repeats analysis). It resulted in a clustering of 23.6% of the isolates and a rate of recent transmission of 14.1%. The clustered isolates mainly belonged to the Haarlem family (23.2%), followed by the Beijing (9.8%), Latin American and Mediterranean (LAM; 8%), and East African-Indian (EAI; 6.2… CONTINUE READING

    Tables and Topics from this paper.

    Three-Year Longitudinal Study of Genotypes of Mycobacterium tuberculosis Isolates in Tuscany, Italy
    • 33
    • PDF
    Molecular Epidemiology of Tuberculosis in Finland, 2008-2011
    • 29
    • PDF


    Publications referenced by this paper.
    Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.
    • 2,643
    • PDF
    The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods.
    • 1,091
    • Highly Influential
    Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods.
    • 806
    • Highly Influential
    Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia.
    • 667
    • PDF
    Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.
    • 278
    • Highly Influential
    • PDF
    Global trends in resistance to antituberculosis drugs.
    • 627